Skip to content

GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030. 

Read More

Back To Top